Taysha Gene Therapies, Inc. (TSHA) Net Margin
- 2025-12-31: Net Margin -507.77%.
- 2025-06-30: Net Margin -1353.58%.
- 2025-03-31: Net Margin -935.23%.
- 2024-12-31: Net Margin -929.03%.
Complete source-backed net margin history.
- Available history
- 2022-12-31 to 2025-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -507.77% |
| 2025-06-30 | -1353.58% |
| 2025-03-31 | -935.23% |
| 2024-12-31 | -929.03% |
| 2024-09-30 | -1427.52% |
| 2024-06-30 | -1882.01% |
| 2024-03-31 | -705.39% |
| 2023-12-31 | 1324.67% |
| 2023-09-30 | -2467.07% |
| 2023-06-30 | -1027.06% |
| 2023-03-31 | -374.46% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -1115.27% |
| 2024-12-31 | -1071.62% |
| 2023-12-31 | -722.06% |
| 2022-12-31 | -6635.25% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |